-
Uncategorized3 weeks ago
Biopharma professionals increasingly accept underemployment
Biopharma professionals increasingly accept underemployment
-
Uncategorized3 weeks ago
MIT scientists discover amino acid that helps the gut heal itself
MIT scientists have identified cysteine — an amino acid found in foods like meat, dairy, beans, and nuts — as a potent trigger for intestinal repair....
-
Uncategorized3 weeks ago
De novo design of miniproteins targeting GPCRs
De novo design of miniproteins targeting GPCRs
-
Uncategorized3 weeks ago
Real-time volumetric imaging of cells and molecules in deep tissues with Takoyaki ultrasound
Post Content
-
Uncategorized3 weeks ago
AI-guided redesign of laboratory-evolved reverse transcriptases enhances prime editing
Nature Biotechnology, Published online: 21 May 2026; doi:10.1038/s41587-026-03149-6 A computational redesign strategy improves evolved prime editors.
-
Uncategorized3 weeks agoCongressional Democrats try to force a vote to end Medicare AI prior authorization pilot
Senate and House Democrats introduced resolutions Wednesday to overturn a Medicare pilot that uses artificial intelligence to approve or deny care. The technology experiment has led...
-
Uncategorized3 weeks agoSmile Please: Wisconsin Welcomes FUJIFILM Cellular Dynamics New Headquarters
In January 2012, Kodak, a name synonymous with analog photography, filed for Chapter 11 bankruptcy protection, an event caused in part by the company’s inability to...
-
Uncategorized3 weeks ago
HELIX AI Model Accurately Predicts RNA Splicing, Unlocks Precision Medicine
HELIX AI Model Accurately Predicts RNA Splicing, Unlocks Precision Medicine
-
Uncategorized3 weeks agoSTAT+: Pioneering trial for treating genetic disease before birth nears reality
SAN FRANCISCO — While Tippi MacKenzie was a postdoctoral fellow in the early 2000s, she and her lab mates experimented with using the then-new technology of...
-
Uncategorized3 weeks ago
I&I biotech cAMPfield attracts top-tier investors in $180M Series A
I&I biotech cAMPfield attracts top-tier investors in $180M Series A
Amgen shores up Tavneos’ FDA defense with Duke data analysis
